Xiamen Amoytop Biotech Co., Ltd. (SHA: 688278)
China
· Delayed Price · Currency is CNY 73.72
-0.60 (-0.81%)
Nov 21, 2024, 11:29 AM CST
Xiamen Amoytop Biotech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2016 |
| Market Capitalization | 30,018 | 21,296 | 15,837 | 11,911 | 13,872 | - | Upgrade
|
| Market Cap Growth | 84.43% | 34.47% | 32.96% | -14.13% | - | - | Upgrade
|
| Enterprise Value | 29,443 | 20,670 | 15,360 | 11,446 | 13,419 | - | Upgrade
|
| Last Close Price | 73.79 | 51.97 | 38.45 | 28.81 | 33.50 | - | Upgrade
|
| PE Ratio | 40.55 | 38.34 | 55.18 | 65.73 | 119.00 | - | Upgrade
|
| Forward PE | 29.62 | 28.12 | 28.12 | 28.12 | 64.34 | - | Upgrade
|
| PS Ratio | 11.57 | 10.14 | 10.37 | 10.52 | 17.47 | - | Upgrade
|
| PB Ratio | 13.26 | 11.35 | 11.25 | 10.26 | 13.87 | - | Upgrade
|
| P/TBV Ratio | 13.98 | 12.64 | 12.32 | 11.74 | 16.75 | - | Upgrade
|
| P/FCF Ratio | 218.12 | 95.22 | 109.98 | 271.60 | - | - | Upgrade
|
| P/OCF Ratio | 69.21 | 41.59 | 43.61 | 50.73 | 149.79 | - | Upgrade
|
| EV/Sales Ratio | 11.35 | 9.84 | 10.06 | 10.11 | 16.90 | - | Upgrade
|
| EV/EBITDA Ratio | 32.12 | 29.03 | 38.09 | 43.97 | 81.31 | - | Upgrade
|
| EV/EBIT Ratio | 34.55 | 31.32 | 42.66 | 51.64 | 105.77 | - | Upgrade
|
| EV/FCF Ratio | 213.94 | 92.42 | 106.67 | 260.99 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.02 | 0.02 | 0.11 | Upgrade
|
| Debt / EBITDA Ratio | 0.01 | 0.01 | 0.02 | 0.10 | 0.11 | 0.41 | Upgrade
|
| Debt / FCF Ratio | 0.07 | 0.04 | 0.07 | 0.57 | - | 0.77 | Upgrade
|
| Asset Turnover | 1.08 | 1.02 | 0.96 | 0.87 | 0.80 | 0.97 | Upgrade
|
| Inventory Turnover | 0.85 | 0.90 | 1.39 | 1.18 | 1.01 | 1.30 | Upgrade
|
| Quick Ratio | 3.43 | 2.80 | 3.04 | 4.00 | 5.76 | 2.41 | Upgrade
|
| Current Ratio | 4.32 | 3.32 | 3.57 | 4.71 | 6.72 | 2.95 | Upgrade
|
| Return on Equity (ROE) | 37.46% | 33.83% | 22.35% | 16.76% | 14.91% | 12.10% | Upgrade
|
| Return on Assets (ROA) | 22.10% | 19.99% | 14.09% | 10.59% | 8.00% | 9.09% | Upgrade
|
| Return on Capital (ROIC) | 26.81% | 24.98% | 17.29% | 12.56% | 9.65% | 11.42% | Upgrade
|
| Earnings Yield | 2.47% | 2.61% | 1.81% | 1.52% | 0.84% | - | Upgrade
|
| FCF Yield | 0.46% | 1.05% | 0.91% | 0.37% | -0.19% | - | Upgrade
|
| Dividend Yield | 0.55% | 0.79% | 0.55% | 0.35% | 0.15% | - | Upgrade
|
| Payout Ratio | 22.52% | 15.60% | 14.17% | 11.41% | 10.92% | 5.27% | Upgrade
|
| Buyback Yield / Dilution | -1.35% | -0.29% | -0.39% | -0.18% | -12.54% | 10.72% | Upgrade
|
| Total Shareholder Return | -0.80% | 0.50% | 0.16% | 0.17% | -12.39% | 10.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.